Bydureon bcise and Humalog drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Bydureon bcise (exenatide) and Humalog (insulin lispro recombinant). Common drug interactions include cardiac disorder among females and injection site haemorrhage among males.
The phase IV clinical study analyzes what interactions people have when they take Bydureon bcise and Humalog. It is created by eHealthMe based on reports of 223 people who take the same drugs from the FDA, and is updated regularly.
What is Bydureon bcise?
Bydureon bcise has active ingredients of exenatide. eHealthMe is studying from 13,812 Bydureon bcise users. Check the latest studies of Bydureon bcise.
What is Humalog?
Humalog has active ingredients of insulin lispro recombinant. It is often used in diabetes. eHealthMe is studying from 137,127 Humalog users. Check the latest studies of Humalog.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
223 people who take Bydureon bcise and Humalog together, and have interactions are studied.
What are the common drug interactions of Bydureon bcise and Humalog, by gender? *
What are the common drug interactions of Bydureon bcise and Humalog, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Bydureon bcise and Humalog?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Bydureon bcise (13,812 reports)
- Humalog (137,127 reports)
Browse all drug interactions of Bydureon bcise and Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Bydureon bcise:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Humalog:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Bydureon bcise and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Humalog and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on exenatide and insulin lispro recombinant (the active ingredients of Bydureon bcise and Humalog, respectively), and Bydureon bcise and Humalog (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Trikafta cause Cognitive Disorder? - 10 seconds ago
- Could Doxorubicin Hydrochloride cause Neutrophil Count Decreased? - 16 seconds ago
- Eosinophil Count Increased and Dyspnea Exacerbated - 19 seconds ago
- Sustiva vs. Truvada, side effect and effectiveness comparison - 33 seconds ago
- Claritin and Blood Pressure Decreased for Women aged 20-29 - 37 seconds ago
- Claritin and Low Blood Pressure for Women aged 20-29 - 37 seconds ago
- Claritin and Hypotension for Women aged 20-29 - 37 seconds ago
- Could Nifedipine cause Sedation Aggravated? - a minute ago
- Quinidine Sulfate vs. Vicodin, side effect and effectiveness comparison - a minute ago
- Could Carvedilol cause Hand Deformity? - a minute ago